CN1933827B - 亚甲基酰胺衍生物在制备治疗和/或预防心力衰竭的药物中的用途 - Google Patents
亚甲基酰胺衍生物在制备治疗和/或预防心力衰竭的药物中的用途 Download PDFInfo
- Publication number
- CN1933827B CN1933827B CN2005800087220A CN200580008722A CN1933827B CN 1933827 B CN1933827 B CN 1933827B CN 2005800087220 A CN2005800087220 A CN 2005800087220A CN 200580008722 A CN200580008722 A CN 200580008722A CN 1933827 B CN1933827 B CN 1933827B
- Authority
- CN
- China
- Prior art keywords
- amino
- benzyl
- oxo
- acetic acid
- carbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
Claims (3)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04100778 | 2004-02-27 | ||
EP04100778.2 | 2004-02-27 | ||
PCT/EP2005/050823 WO2005082347A1 (en) | 2004-02-27 | 2005-02-25 | Use of methylene amide derivatives in cardiovascular disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1933827A CN1933827A (zh) | 2007-03-21 |
CN1933827B true CN1933827B (zh) | 2011-07-27 |
Family
ID=34896106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2005800087220A Expired - Fee Related CN1933827B (zh) | 2004-02-27 | 2005-02-25 | 亚甲基酰胺衍生物在制备治疗和/或预防心力衰竭的药物中的用途 |
Country Status (24)
Country | Link |
---|---|
US (1) | US20070185118A1 (zh) |
EP (1) | EP1732534B1 (zh) |
JP (1) | JP5001138B2 (zh) |
KR (1) | KR101188940B1 (zh) |
CN (1) | CN1933827B (zh) |
AT (1) | ATE401877T1 (zh) |
AU (1) | AU2005216649B2 (zh) |
BR (1) | BRPI0508080A (zh) |
CA (1) | CA2554919C (zh) |
CY (1) | CY1108252T1 (zh) |
DE (1) | DE602005008412D1 (zh) |
DK (1) | DK1732534T3 (zh) |
EA (1) | EA011811B1 (zh) |
ES (1) | ES2308458T3 (zh) |
HK (1) | HK1098073A1 (zh) |
HR (1) | HRP20080367T3 (zh) |
IL (1) | IL177494A (zh) |
NO (1) | NO20064295L (zh) |
PL (1) | PL1732534T3 (zh) |
PT (1) | PT1732534E (zh) |
RS (1) | RS50596B (zh) |
SI (1) | SI1732534T1 (zh) |
UA (1) | UA84453C2 (zh) |
WO (1) | WO2005082347A1 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003064376A1 (en) * | 2002-01-29 | 2003-08-07 | Applied Research Systems Ars Holding N.V. | Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps) |
EP1654247B1 (en) | 2003-07-21 | 2010-01-20 | Merck Serono SA | Alkynyl aryl carboxamides |
EP2072498A4 (en) | 2006-10-12 | 2012-07-18 | Inst Med Molecular Design Inc | N-PHENYLOXAMIDE ACID DERIVATIVE |
US8633245B2 (en) * | 2008-04-11 | 2014-01-21 | Institute Of Medicinal Molecular Design, Inc. | PAI-1 inhibitor |
TW201313884A (zh) | 2011-08-29 | 2013-04-01 | Ticona Llc | 液晶聚合物之固態聚合 |
US9057016B2 (en) | 2011-08-29 | 2015-06-16 | Ticona Llc | Melt polymerization of low melt viscosity liquid crystalline polymers |
KR20140057360A (ko) | 2011-08-29 | 2014-05-12 | 티코나 엘엘씨 | 고유동성 액정 중합체 조성물 |
WO2013032975A1 (en) | 2011-08-29 | 2013-03-07 | Ticona Llc | Thermotropic liquid crystalline polymer with improved low shear viscosity |
US8778221B2 (en) | 2011-08-29 | 2014-07-15 | Ticona Llc | Aromatic amide compound |
WO2013032967A1 (en) | 2011-08-29 | 2013-03-07 | Ticona Llc | Cast molded parts formed form a liquid crystalline polymer |
US8852730B2 (en) | 2011-08-29 | 2014-10-07 | Ticona Llc | Melt-extruded substrate for use in thermoformed articles |
CN103764794B (zh) | 2011-08-29 | 2016-05-18 | 提克纳有限责任公司 | 高流动液晶聚合物组合物 |
JP2014525499A (ja) | 2011-08-29 | 2014-09-29 | ティコナ・エルエルシー | 低い融解温度をもつ耐熱性液晶ポリマー組成物 |
US20150337212A1 (en) | 2012-12-17 | 2015-11-26 | Shell Oil Company | Integrated gas-to-liquids condensate process |
WO2014130275A2 (en) | 2013-02-22 | 2014-08-28 | Ticona Llc | High performance polymer composition with improved flow properties |
WO2014197659A1 (en) | 2013-06-07 | 2014-12-11 | Ticona Llc | High strength thermotropic liquid crystalline polymer |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001019830A1 (en) * | 1999-09-10 | 2001-03-22 | Novo Nordisk A/S | MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
WO2003064376A1 (en) * | 2002-01-29 | 2003-08-07 | Applied Research Systems Ars Holding N.V. | Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627767B2 (en) * | 2000-08-29 | 2003-09-30 | Abbott Laboratories | Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors |
DE10117823A1 (de) * | 2001-04-10 | 2002-10-17 | Merck Patent Gmbh | Oxalsäurederivate |
AR034373A1 (es) * | 2001-06-07 | 2004-02-18 | Wyeth Corp | Inhibidores de ptpasa para mejorar el perfil de riesgo cardiovascular |
AR034374A1 (es) * | 2001-06-07 | 2004-02-18 | Wyeth Corp | Combinacion de un inhibidor de ptpasa y un inhibidor de ace |
-
2005
- 2005-02-25 US US10/590,808 patent/US20070185118A1/en not_active Abandoned
- 2005-02-25 ES ES05716814T patent/ES2308458T3/es active Active
- 2005-02-25 PT PT05716814T patent/PT1732534E/pt unknown
- 2005-02-25 AU AU2005216649A patent/AU2005216649B2/en not_active Ceased
- 2005-02-25 EA EA200601511A patent/EA011811B1/ru not_active IP Right Cessation
- 2005-02-25 UA UAA200609879A patent/UA84453C2/ru unknown
- 2005-02-25 SI SI200530349T patent/SI1732534T1/sl unknown
- 2005-02-25 JP JP2007500226A patent/JP5001138B2/ja not_active Expired - Fee Related
- 2005-02-25 CN CN2005800087220A patent/CN1933827B/zh not_active Expired - Fee Related
- 2005-02-25 DK DK05716814T patent/DK1732534T3/da active
- 2005-02-25 KR KR1020067019715A patent/KR101188940B1/ko not_active IP Right Cessation
- 2005-02-25 AT AT05716814T patent/ATE401877T1/de active
- 2005-02-25 EP EP05716814A patent/EP1732534B1/en active Active
- 2005-02-25 WO PCT/EP2005/050823 patent/WO2005082347A1/en active Application Filing
- 2005-02-25 BR BRPI0508080-0A patent/BRPI0508080A/pt not_active IP Right Cessation
- 2005-02-25 CA CA2554919A patent/CA2554919C/en not_active Expired - Fee Related
- 2005-02-25 PL PL05716814T patent/PL1732534T3/pl unknown
- 2005-02-25 RS RSP-2008/0353A patent/RS50596B/sr unknown
- 2005-02-25 DE DE602005008412T patent/DE602005008412D1/de active Active
-
2006
- 2006-08-15 IL IL177494A patent/IL177494A/en not_active IP Right Cessation
- 2006-09-22 NO NO20064295A patent/NO20064295L/no not_active Application Discontinuation
-
2007
- 2007-05-28 HK HK07105603.1A patent/HK1098073A1/xx not_active IP Right Cessation
-
2008
- 2008-07-24 HR HR20080367T patent/HRP20080367T3/xx unknown
- 2008-08-11 CY CY20081100844T patent/CY1108252T1/el unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001019830A1 (en) * | 1999-09-10 | 2001-03-22 | Novo Nordisk A/S | MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
WO2003064376A1 (en) * | 2002-01-29 | 2003-08-07 | Applied Research Systems Ars Holding N.V. | Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps) |
Non-Patent Citations (5)
Title |
---|
Fleming I. et al.Ca2+-independent activation of theendothelialnitricoxidesynthase in response to tyrosinephosphataseinhibitorsandfluid shear stress.Circulation Research82 6.1998,82(6),p.692左栏第10-12行. |
Fleming I. et al.Ca2+-independent activation of theendothelialnitricoxidesynthase in response to tyrosinephosphataseinhibitorsandfluid shear stress.Circulation Research82 6.1998,82(6),p.692左栏第10-12行. * |
全文. |
葛德元等,.心力衰竭的药物治疗 第2版.科学技术文献出版社,2000,p.129第1-3行. |
葛德元等,.心力衰竭的药物治疗 第2版.科学技术文献出版社,2000,p.129第1-3行. * |
Also Published As
Publication number | Publication date |
---|---|
PT1732534E (pt) | 2008-08-08 |
US20070185118A1 (en) | 2007-08-09 |
EP1732534A1 (en) | 2006-12-20 |
SI1732534T1 (sl) | 2008-10-31 |
JP2007524701A (ja) | 2007-08-30 |
HRP20080367T3 (en) | 2008-09-30 |
BRPI0508080A (pt) | 2007-07-17 |
ATE401877T1 (de) | 2008-08-15 |
ES2308458T3 (es) | 2008-12-01 |
PL1732534T3 (pl) | 2008-12-31 |
KR20060129066A (ko) | 2006-12-14 |
NO20064295L (no) | 2006-09-22 |
JP5001138B2 (ja) | 2012-08-15 |
EA200601511A1 (ru) | 2007-02-27 |
EP1732534B1 (en) | 2008-07-23 |
IL177494A (en) | 2011-06-30 |
IL177494A0 (en) | 2006-12-31 |
UA84453C2 (ru) | 2008-10-27 |
CN1933827A (zh) | 2007-03-21 |
CA2554919A1 (en) | 2005-09-09 |
AU2005216649A1 (en) | 2005-09-09 |
KR101188940B1 (ko) | 2012-10-08 |
DK1732534T3 (da) | 2008-11-17 |
EA011811B1 (ru) | 2009-06-30 |
HK1098073A1 (en) | 2007-07-13 |
WO2005082347A1 (en) | 2005-09-09 |
DE602005008412D1 (de) | 2008-09-04 |
AU2005216649B2 (en) | 2010-09-09 |
CY1108252T1 (el) | 2014-02-12 |
RS50596B (sr) | 2010-05-07 |
CA2554919C (en) | 2013-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1933827B (zh) | 亚甲基酰胺衍生物在制备治疗和/或预防心力衰竭的药物中的用途 | |
CN107223125B (zh) | sGC刺激剂 | |
WO2013009830A1 (en) | Methods of treatment | |
US20060178349A1 (en) | Compositions and therapeutic methods utilizing a combination of a 5-HT1F inhibitor and an NSAID | |
CN107847499A (zh) | 治疗神经退行性疾病的方法 | |
KR20080040643A (ko) | 의약의 병용 및 그 용도 | |
PT2637664T (pt) | Composições e métodos de tratamento de hipertensão pulmonar | |
KR20220082804A (ko) | 심장 근섬유분절 억제제 경구 제제들 | |
US20170065608A1 (en) | Prophylactic or therapeutic agent for neuropathic pain associated with guillain-barre syndrome | |
CN102046164B (zh) | 烟碱性受体部分激动剂和乙酰胆碱酯酶抑制剂的组合、含有所述组合的药物组合物及其在治疗认知障碍中的用途 | |
US9115123B2 (en) | Preventive or therapeutic agent for pain associated with herpes zoster in acute phase | |
JP2002506024A (ja) | 急性冠動脈虚血症候群および関連状態に対する併用療法および組成物 | |
US20090312311A1 (en) | Combination of organic compounds | |
CN108904516A (zh) | 肌苷在防治抑郁症中的应用 | |
JP6447496B2 (ja) | 多発性硬化症の治療剤又は予防剤 | |
WO1997035615A1 (en) | Compositions and methods for inhibiting clot formation | |
US20230055568A1 (en) | Therapeutic agent for myalgic encephalomyelitis/chronic fatigue syndrome | |
ES2289305T3 (es) | Medicamento para el tratamiento del "sindrome de la respuesta inflamatoria sistemica". | |
CN104144688B (zh) | p75受体拮抗剂的治疗用途 | |
WO2021108303A1 (en) | Pharmaceutical compositions for the treatment of pulmonary hypertension | |
CN106333953A (zh) | 尤克那非新用途 | |
TWI462923B (zh) | Kmup-3之心肌梗塞疾患用途 | |
Lumb | Promising new inotropes for the treatment of heart failure | |
Ponder et al. | 598. Mitral Valve Disease Is Due to Abnormal Collagen Structure in Canine Mucopolysaccharidosis I and VII and Can Be Reduced with Neonatal Intravenous Injection of a Gamma Retroviral Vector | |
MXPA06011575A (en) | Composition comprising a jnk inhibitor and cyclosporin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1098073 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: SERONO LABORATORY CO., LTD. Free format text: FORMER OWNER: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. Effective date: 20080516 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20080516 Address after: Swiss Coyne Hince Applicant after: Serono Lab Address before: Curacao, Netherlands Antilles Applicant before: Applied Research Systems ARS Holding N. V. |
|
ASS | Succession or assignment of patent right |
Owner name: MERCK SERONO CO., LTD. Free format text: FORMER OWNER: SERONO LABORATORIES LTD. Effective date: 20100324 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: SWITZERLAND COINSIMS TO: COINSINS, SWITZERLAND |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100324 Address after: Swiss Coyne Hince Applicant after: Merck Serono S. A. Address before: Switzerland Cohen Sins Applicant before: Serono Lab |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1098073 Country of ref document: HK |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110727 Termination date: 20150225 |
|
EXPY | Termination of patent right or utility model |